Benzinga | May 5, 2021 04:19PM EDT

Aerie Pharmaceuticals Q1 EPS $(0.72) Misses $(0.68) Estimate, Sales $23.00M Beat $22.78M Estimate

Aerie Pharmaceuticals (NASDAQ:AERI) reported quarterly losses of $(0.72) per share which missed the analyst consensus estimate of $(0.68) by 5.88 percent. This is a 14.29 percent increase over losses of $(0.84) per share from the same period last year. The company reported quarterly sales of $23.00 million which beat the analyst consensus estimate of $22.78 million by 0.97 percent. This is a 13.07 percent increase over sales of $20.34 million the same period last year.